As director of Pew's prescription drug abuse project, Reilly works on federal and state initiatives to reduce the health and economic consequences of prescription drug abuse.
Prior to joining Pew, Reilly worked on issues related to the safety and quality of medication use for the American Society of Health-System Pharmacists in Bethesda, Maryland. Areas of focus included the development of clinical policy, dissemination of best practices to improve patient outcomes, and coordination of initiatives aimed at ensuring the availability and integrity of drug products. In this role, she coordinated the society’s work in support of rescheduling hydrocodone combination products from Schedule III to Schedule II to improve the safe and appropriate use of those therapies. In addition, she led development of policy that called on clinicians to increase efforts to combat prescription drug abuse while also ensuring patient access to needed pain therapies.
Reilly received her bachelor’s degree in pharmacy from Temple University in Philadelphia, Pennsylvania. She is currently enrolled in the master’s program in health and medical policy at George Mason University.
Pew Offers Support for Drug Management Programs in Prescription Drug Abuse and Prevention Act of 2015
On June 4, Pew sent a letter to Senators Joe Manchin (D-WV), Angus King (I-ME), and Shelley Moore Capito (R-WV), offering support for select provisions in the Prescription Drug Abuse and Prevention Act of 2015. These provisions would allow Medicare Part D plan sponsors to require patients at risk of drug abuse to use pre-designated pharmacies and providers to obtain prescriptions for opioids and... Read More
This week, the House Energy and Commerce Committee held a markup on the 21st Century Cures Act, legislation designed to speed the discovery, development, and delivery of lifesaving drugs and devices. As part of this proposal, legislators included provisions that can help address America’s prescription drug abuse epidemic. Read More
On Monday, January 12, The Pew Charitable Trusts submitted a letter to the Medicare Payment Advisory Commission (MedPAC) encouraging the organization to recommend that Congress allow patient review and restriction (PRR) programs in Medicare Part D. PRR programs are a tool already utilized in some commercial insurance plans as well as state Medicaid programs to support the safe and appropriate use... Read More